Cited by 50TGF-β signaling in diseasesGDF15 and Related BiomarkersAdipokines, Inflammation, and Metabolic Diseases

Bone morphogenetic proteins and growth differentiation factors as drug targets in cardiovascular and metabolic disease

Tobin, James F., Celeste, Anthony J.·2006·Drug Discovery Today

Abstract

Bone morphogenetic proteins (BMPs) and growth differentiation factors (GDFs) control the development and homeostasis of multiple tissue types in many organisms, from humans to invertebrates. These morphogens are expressed in a tissue-specific manner and they signal by binding to serine-threonine kinase receptors, resulting in coordinated changes in gene expression that regulate the differentiation and development of multiple tissue types. In addition, these proteins are regulated post-transcriptionally through binding to several soluble proteins. In this review we focus on a subset of BMPs and GDFs that have been implicated in the pathophysiology of type 2 diabetes and cardiovascular disease.

Integrity signals

Registry

Crossref · 10.1016/j.drudis.2006.03.016

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • BMP-7 is a multifunctional cytokine and has been implicated as a potential therapeutic agent for cardiovascular, metabolic, and degenerative diseases, mostly validated in mouse models.

    “Originally identified as a bone inducer, BMP-7 is now being recognized as a multifunctional cytokine and has been implicated as a potential therapeutic agent for cardiovascular, metabolic, and degenerative diseases as mostly validated in mouse models 122.”

    From Cellular bioenergetics as a target for obesity therapy (2010) · cites this paper as [122]

Cites

Flagged first, then by citations

1 of the 73 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Tobin, J. F., & Celeste, A. J.
Affiliations
Wyeth (US)
Corresponding author
Tobin, James F.
Venue
Drug Discovery Today
Publisher
Elsevier BV
Published
2006-05
Volume
11
Issue
9-10
Pages
405-411
ISSN
1359-6446 (ISSN-L)
OpenAlex
W1981731801
Cited by
50
References
73
Citations by year
2026: 1 · 2025: 3 · 2024: 2 · 2023: 2 · 2021: 2 · 2020: 5 · 2019: 4 · 2018: 2 · 2017: 2 · 2016: 2 · 2014: 3 · 2013: 3 · 2012: 4
FWCI
0.13
Type
journal article
Language
en
Open access
closed
Locations
  • Drug Discovery Today (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Health Sciences › Medicine › Rheumatology › GDF15 and Related Biomarkers
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
Keywords
bone morphogenetic proteins, growth differentiation factor, therapeutic target, type 2 diabetes, cardiovascular disease, morphogen signaling, serine/threonine kinase receptors, post-transcriptional regulation, tissue-specific gene expression
MeSH terms
Animals, Cardiovascular Agents, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Humans, Hypertension, Pulmonary, Hypoglycemic Agents, Kidney Diseases, Metabolic Diseases, Signal Transduction, Transforming Growth Factor beta, Bone Morphogenetic Proteins, Intercellular Signaling Peptides and Proteins, Atherosclerosis, Bone Morphogenetic Protein Receptors, Bone Morphogenetic Protein 7, Growth Differentiation Factor 3

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review